Association of TGF-β1 expression with the effects of tamoxifen on estrogen receptor positive and negative breast cancer cells

Effects of Tamoxifen on Breast Cancer Cells

publication

Author Information

Author(s): Roger R Perry, Yuan Kang, Bridget Greaves

Primary Institution: Eastern Virginia Medical School

Hypothesis

The study investigates the role of TGF-β in the effects of tamoxifen on both estrogen receptor-positive and negative breast cancer cells.

Conclusion

Tamoxifen induces TGF-β expression through an ER-independent mechanism in both ER-positive and ER-negative breast cancer cells.

Supporting Evidence

  • TGF-β expression was induced by tamoxifen in both ER-positive and ER-negative cells.
  • The addition of estrogen did not inhibit tamoxifen-induced TGF-β expression.
  • Tamoxifen-induced DNA cleavage was correlated with TGF-β levels.

Takeaway

Tamoxifen can help fight breast cancer by affecting both types of cancer cells, even those that don't have estrogen receptors.

Methodology

The study examined the effects of tamoxifen on different breast cancer cell lines and measured TGF-β expression and DNA cleavage.

Limitations

The study does not clarify the in vivo therapeutic effectiveness of tamoxifen at different concentrations.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication